These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 3160727

  • 1. Effects of plasmin on von Willebrand factor multimers. Degradation in vitro and stimulation of release in vivo.
    Hamilton KK, Fretto LJ, Grierson DS, McKee PA.
    J Clin Invest; 1985 Jul; 76(1):261-70. PubMed ID: 3160727
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Sialic acid prevents loss of large von Willebrand factor multimers by protecting against amino-terminal proteolytic cleavage.
    Berkowitz SD, Federici AB.
    Blood; 1988 Nov; 72(5):1790-6. PubMed ID: 2460162
    [Abstract] [Full Text] [Related]

  • 4. Effect of carbohydrate modifications of factor VIII/von Willebrand factor on binding to platelets.
    Goudemand J, Mazurier C, Samor B, Bouquelet S, Montreuil J, Goudemand M.
    Thromb Haemost; 1985 Jun 24; 53(3):390-5. PubMed ID: 2864750
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Evidence that a secondary binding and protecting site for factor VIII on von Willebrand factor is highly unlikely.
    Layet S, Girma JP, Obert B, Peynaud-Debayle E, Bihoreau N, Meyer D.
    Biochem J; 1992 Feb 15; 282 ( Pt 1)(Pt 1):129-37. PubMed ID: 1531749
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Plasmin effect on platelet glycoprotein Ib-von Willebrand factor interactions.
    Adelman B, Michelson AD, Loscalzo J, Greenberg J, Handin RI.
    Blood; 1985 Jan 15; 65(1):32-40. PubMed ID: 3155489
    [Abstract] [Full Text] [Related]

  • 12. Disulfide bonds required to assemble functional von Willebrand factor multimers.
    Dong Z, Thoma RS, Crimmins DL, McCourt DW, Tuley EA, Sadler JE.
    J Biol Chem; 1994 Mar 04; 269(9):6753-8. PubMed ID: 8120035
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparative analysis and classification of von Willebrand factor/factor VIII concentrates: impact on treatment of patients with von Willebrand disease.
    Budde U, Metzner HJ, Müller HG.
    Semin Thromb Hemost; 2006 Sep 04; 32(6):626-35. PubMed ID: 16977573
    [Abstract] [Full Text] [Related]

  • 16. Epitope mapping of the von Willebrand factor subunit distinguishes fragments present in normal and type IIA von Willebrand disease from those generated by plasmin.
    Berkowitz SD, Dent J, Roberts J, Fujimura Y, Plow EF, Titani K, Ruggeri ZM, Zimmerman TS.
    J Clin Invest; 1987 Feb 04; 79(2):524-31. PubMed ID: 2433308
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Recessive von Willebrand disease type 2 Normandy: variable expression of mild hemophilia and VWD type 1.
    Michiels JJ, Gadisseur A, Vangenegten I, Schroyens W, Berneman Z.
    Acta Haematol; 2009 Feb 04; 121(2-3):119-27. PubMed ID: 19506358
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.